He, W., Shu, X., Zhu, E., Deng, B., Lin, Y., Wu, X., . . . Nie, R. (2021). Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease. BMC Cardiovasc Disord.

He, Wanbing, Xiaorong Shu, Enyi Zhu, Bingqing Deng, Yongqing Lin, Xiaoying Wu, Zenan Zhou, Jingfeng Wang, and Ruqiong Nie. "Intermittent Concurrent Use of Clopidogrel and Proton Pump Inhibitors Did Not Increase Risk of Adverse Clinical Outcomes in Chinese Patients With Coronary Artery Disease." BMC Cardiovasc Disord 2021.

He, Wanbing, et al. "Intermittent Concurrent Use of Clopidogrel and Proton Pump Inhibitors Did Not Increase Risk of Adverse Clinical Outcomes in Chinese Patients With Coronary Artery Disease." BMC Cardiovasc Disord 2021.